PLSE
Pulse Biosciences, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$53.24
−2.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 883.07x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 38.16x
- Price / sales
- 3204.40x
- Price / cash flow
- -62.15x
Enterprise value
- Enterprise value
- $3.7B
- EV / sales
- 3124.36x
- EV / EBITDA
- -46.36x
- EV / EBIT
- -44.58x
- Market cap
- $3.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026